As of 2025-09-15, the Relative Valuation of Novacyt SA (ALNOV.PA) is (17.94) EUR. This relative valuation is based on P/E multiples. With the latest stock price at 0.46 EUR, the upside of Novacyt SA based on Relative Valuation is -3979.7%.
The range of the Relative Valuation is (17.03) - (18.48) EUR.
Note: valuation result may not be accurate due to the company's negative earnings.
| Range | Selected | |
| Trailing P/E multiples | 28.8x - 40.4x | 34.5x |
| Forward P/E multiples | 23.3x - 31.3x | 26.2x |
| Fair Price | (17.03) - (18.48) | (17.94) |
| Upside | -3781.6% - -4096.0% | -3979.7% |
| Date | P/E |
| 2025-09-11 | -0.80 |
| 2025-09-10 | -0.81 |
| 2025-09-09 | -0.75 |
| 2025-09-08 | -0.76 |
| 2025-09-05 | -0.76 |
| 2025-09-04 | -0.77 |
| 2025-09-03 | -0.76 |
| 2025-09-02 | -0.77 |
| 2025-09-01 | -0.78 |
| 2025-08-29 | -0.80 |
| 2025-08-28 | -0.80 |
| 2025-08-27 | -0.80 |
| 2025-08-26 | -0.79 |
| 2025-08-25 | -0.82 |
| 2025-08-22 | -0.80 |
| 2025-08-21 | -0.81 |
| 2025-08-20 | -0.79 |
| 2025-08-19 | -0.80 |
| 2025-08-18 | -0.82 |
| 2025-08-15 | -0.80 |
| 2025-08-14 | -0.83 |
| 2025-08-13 | -0.88 |
| 2025-08-12 | -0.75 |
| 2025-08-11 | -0.75 |
| 2025-08-08 | -0.75 |
| 2025-08-07 | -0.76 |
| 2025-08-06 | -0.76 |
| 2025-08-05 | -0.76 |
| 2025-08-04 | -0.75 |
| 2025-08-01 | -0.77 |
| 2025-07-31 | -0.78 |
| 2025-07-30 | -0.79 |
| 2025-07-29 | -0.79 |
| 2025-07-28 | -0.79 |
| 2025-07-25 | -0.81 |
| 2025-07-24 | -0.82 |
| 2025-07-23 | -0.79 |
| 2025-07-22 | -0.78 |
| 2025-07-21 | -0.79 |
| 2025-07-18 | -0.79 |
| 2025-07-17 | -0.80 |
| 2025-07-16 | -0.80 |
| 2025-07-15 | -0.80 |
| 2025-07-14 | -0.80 |
| 2025-07-11 | -0.80 |
| 2025-07-10 | -0.80 |
| 2025-07-09 | -0.80 |
| 2025-07-08 | -0.79 |
| 2025-07-07 | -0.81 |
| 2025-07-04 | -0.81 |